Temasek Life Sciences Private Ltd
Insider CIK 1379349 · GH 10% owner · NTLA 10% owner · FIXX 10% owner · VIR 10% owner · AKLI 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKLI Akili, Inc. | U Tender deriv | 2024-07-02 | 2024-07-05 | 1,172,697 | — | $0 | 0 | SEC↗ |
| AKLI Akili, Inc. | U Tender | 2024-07-02 | 2024-07-05 | 10,336,425 | — | $0 | 0 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion deriv | 2019-10-16 | 2019-10-18 | 1,666,666 | — | $0 | 0 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion deriv | 2019-10-16 | 2019-10-18 | 3,333,333 | — | $0 | 0 | SEC↗ |
| VIR Vir Biotechnology, Inc. | P Buy | 2019-10-16 | 2019-10-18 | 500,000 | $20.00 | $10.00M | 5,499,999 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion | 2019-10-16 | 2019-10-18 | 3,333,333 | — | $0 | 3,333,333 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion | 2019-10-16 | 2019-10-18 | 1,666,666 | — | $0 | 4,999,999 | SEC↗ |
| GH Guardant Health, Inc. | C Conversion deriv | 2018-10-09 | 2018-10-11 | 1,016,995 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | C Conversion deriv | 2018-10-09 | 2018-10-11 | 596,012 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | C Conversion | 2018-10-09 | 2018-10-11 | 1,016,995 | — | $0 | 1,016,995 | SEC↗ |
| GH Guardant Health, Inc. | C Conversion | 2018-10-09 | 2018-10-11 | 596,012 | — | $0 | 596,012 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion deriv | 2018-04-02 | 2018-04-04 | 1,605,681 | — | $0 | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion deriv | 2018-04-02 | 2018-04-04 | 989,612 | — | $0 | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | P Buy | 2018-04-02 | 2018-04-04 | 625,000 | $16.00 | $10.00M | 3,220,293 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion | 2018-04-02 | 2018-04-04 | 989,612 | — | $0 | 2,595,293 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion | 2018-04-02 | 2018-04-04 | 1,605,681 | — | $0 | 1,605,681 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion deriv | 2016-05-11 | 2016-05-13 | 490,527 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | P Buy | 2016-05-11 | 2016-05-13 | 300,000 | $18.00 | $5.40M | 790,527 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion | 2016-05-11 | 2016-05-13 | 490,527 | — | $0 | 490,527 | SEC↗ |